| Sign In to gain access to subscriptions and/or personal tools. |
Atherosclerosis in type 2 diabetes: a role for fibrate therapy?University of Toronto, Toronto General Hospital, 200 Elizabeth Street, Toronto, Ontario, Canada, M5G 2C4. Vascular complications associated with type 2 diabetes confer significant morbidity and mortality. Atherosclerosis develops much earlier and progresses more rapidly than in subjects without diabetes. The clustering of cardiovascular risk factors associated with type 2 diabetes is mainly responsible for accelerated atherosclerotic disease. While statins remain the primary lipid-modifying therapy, the pharmacological profile of the fibrates suggests potential as an alternative or additional treatment for reducing the risk of atherosclerotic vascular complications in type 2 diabetes.
Key Words: atherosclerosis dyslipidaemia fibrates type 2 diabetes
Diabetes and Vascular Disease Research, Vol. 4, No. 4,
368-374 (2007) |
|||